Kallistatin, a novel human tissue kallikrein inhibitor: levels in body fluids, blood cells, and tissues in health and disease.
about
Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human geneticsKallistatin is a potent new vasodilatorUpdate of the human and mouse SERPIN gene superfamilyAn overview of the serpin superfamilyThe Potential Role of Kallistatin in the Development of Abdominal Aortic AneurysmNovel roles of kallistatin, a specific tissue kallikrein inhibitor, in vascular remodelingProtection effect of kallistatin on carbon tetrachloride-induced liver fibrosis in rats via antioxidative stressInhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatinKruppel-like factor 4 is a novel mediator of Kallistatin in inhibiting endothelial inflammation via increased endothelial nitric-oxide synthase expression.A proteomic approach for plasma biomarker discovery with iTRAQ labelling and OFFGEL fractionation.Plasma kallistatin in critically ill patients with severe sepsis and septic shock.Pivotal role of JNK-dependent FOXO1 activation in downregulation of kallistatin expression by oxidative stressPlasma kallistatin levels in patients with severe community-acquired pneumonia.Elevated circulation levels of an antiangiogenic SERPIN in patients with diabetic microvascular complications impair wound healing through suppression of Wnt signalingKallistatin antagonizes Wnt/β-catenin signaling and cancer cell motility via binding to low-density lipoprotein receptor-related protein 6Kallistatin inhibits vascular inflammation by antagonizing tumor necrosis factor-alpha-induced nuclear factor kappaB activationLocalization and expression of tissue kallikrein and kallistatin in human blood vessels.The kallikrein-kinin system in humans.Novel role of kallistatin in vascular repair by promoting mobility, viability, and function of endothelial progenitor cells.Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement.Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsisKallistatin protects against sepsis-related acute lung injury via inhibiting inflammation and apoptosis.Kallistatin ameliorates influenza virus pathogenesis by inhibition of kallikrein-related peptidase 1-mediated cleavage of viral hemagglutininKallistatin inhibits TGF-β-induced endothelial-mesenchymal transition by differential regulation of microRNA-21 and eNOS expression.Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosisKallistatin - the score beats the marker.Plasma kallistatin is associated with adiposity and cardiometabolic risk in apparently healthy African American adolescentsTargeting human serum fucome by an integrated liquid-phase multicolumn platform operating in "cascade" to facilitate comparative mass spectrometric analysis of disease-free and breast cancer sera.Kallistatin modulates immune cells and confers anti-inflammatory response to protect mice from group A streptococcal infection.Kallistatin induces breast cancer cell apoptosis and autophagy by modulating Wnt signaling and microRNA synthesis.Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing.Kallistatin protects against bleomycin-induced idiopathic pulmonary fibrosis by inhibiting angiogenesis and inflammation.Intestinal tissue kallikrein-kinin system in inflammatory bowel disease.Kallistatin suppresses cancer development by multi-factorial actions.Kallistatin reduces vascular senescence and aging by regulating microRNA-34a-SIRT1 pathwayIncreased serum kallistatin levels in type 1 diabetes patients with vascular complicationsKallistatin levels in HIV-infected patients and effects of statin therapy.Protective Role of Kallistatin in Vascular and Organ Injury.Immunolocalization and expression of kinin B1R and B2R receptors in human inflammatory bowel disease.SERPINA3K induces apoptosis in human colorectal cancer cells via activating the Fas/FasL/caspase-8 signaling pathway.
P2860
Q21131205-CA30B3B7-8A4A-478F-9AF9-D7DF277193CFQ24561603-DDF808C2-C648-46B5-8245-858CBCF38E97Q24622280-A7F5F98D-7FEC-461E-A8ED-6044DD952250Q24684030-6111D9F7-69D2-48D3-8E18-195053F67871Q26741231-B3A0B229-2B5E-4550-966A-90CE37BE049FQ28205487-93A596F7-47CE-4A10-B30A-8832D9A1860AQ28539856-EDE0006C-77C1-4702-95E4-F751DB9FA555Q30983984-E637339B-8371-47E3-8445-2C69E07578F4Q33512668-E5521E88-1B36-4C5B-85A1-42DA70B5D00CQ33514848-A2E1C22B-7F20-47C1-A546-BE690EEC986EQ33725117-94139A69-7E69-41B3-BBCF-2C3BB3135A29Q33727573-03EC53B2-608D-454F-AD27-0DFA6A0B2E0BQ33752812-0070DAA4-24FC-4F3F-A9C1-BCACAE899AB9Q33787188-121869A6-CEA4-4A2C-A120-A4E3501D6F60Q33939375-7201BF18-BDD4-4BC3-837F-B49C3DD5F849Q34070667-8724749D-945E-4A4C-A5DA-684F7D36CB08Q34487686-16A33E7F-8860-4F8E-83F8-5DD30E2F3382Q34570447-E74959A8-7B63-4936-A64B-D63E5ACBAB94Q35070827-FBFC3065-54AF-47B2-A697-AC812122A83AQ35555319-C91D64C9-4785-4E97-BBBF-0AF1F953B90BQ35654838-96EF2E71-737F-43E3-9FE8-0E5966057354Q35877298-B95317D9-A93B-404C-9011-CD3C1CF58D8FQ35960792-4C446558-63B1-4D48-B866-9AA82F43049FQ36029511-0DF3FA78-E55F-487E-BDF5-F3537C50E51FQ36237963-64728A57-16D3-4EDA-AA09-909D73F5E3ECQ36902902-D6FB7AA7-59CE-4E4E-80E9-4FC48C984545Q37133031-1D26A427-521F-427C-BFA1-D0EF22ECB382Q37155335-3CF101C3-C715-4AD4-8B12-D3C0DF733B17Q37263454-7666CB95-B488-4EF2-92AE-1DBE525D088CQ37370247-EFF554C4-93DA-4AE5-8C68-0296A1B17ED4Q37697813-1A82EF74-C85C-4CCD-BFDD-0BAE194ADCE1Q37732963-FC0D39A3-04C0-40EA-90F2-BE0FF4163258Q37789692-BD61C4A9-857B-42CF-9C21-B7AEA4BBB9E9Q39252905-F143D09F-1DFD-47D0-92D3-3DEB2B3B47C0Q40988610-5980847C-FF4D-4640-92E3-A370F719E3EEQ42034969-13DD5501-CF04-4893-888D-CBDAFDE6F901Q42101794-16DEDD80-122E-4DCA-B5C0-904B2C340A71Q42360588-540BECD7-3E2F-4D90-BD83-17472B1F6C0EQ42476384-D6292332-2293-4EB8-A755-384021B47A2BQ44088705-AF52D6A1-796A-4234-A561-7B1A242A55CA
P2860
Kallistatin, a novel human tissue kallikrein inhibitor: levels in body fluids, blood cells, and tissues in health and disease.
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Kallistatin, a novel human tis ...... tissues in health and disease.
@ast
Kallistatin, a novel human tis ...... tissues in health and disease.
@en
Kallistatin, a novel human tis ...... tissues in health and disease.
@nl
type
label
Kallistatin, a novel human tis ...... tissues in health and disease.
@ast
Kallistatin, a novel human tis ...... tissues in health and disease.
@en
Kallistatin, a novel human tis ...... tissues in health and disease.
@nl
prefLabel
Kallistatin, a novel human tis ...... tissues in health and disease.
@ast
Kallistatin, a novel human tis ...... tissues in health and disease.
@en
Kallistatin, a novel human tis ...... tissues in health and disease.
@nl
P2093
P1476
Kallistatin, a novel human tis ...... tissues in health and disease.
@en
P2093
P304
P356
10.1016/S0022-2143(96)90152-3
P577
1996-06-01T00:00:00Z